Breaking News

Celerion To Support FNIH Biomarkers Consortium

Will provide clinical services to support The Beta Cell Project

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Celerion has been selected by the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium to provide clinical support for The Beta Cell Project, a program of studies designed to standardize biomarker measures of beta cell function. Celerion will provide clinical services to support the development of pharmacodynamic measures with the goal of creating industry standards.   The Biomarkers Consortium is a public-private biomedical research partnership managed by the FNIH aims ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters